Regulation of anti-tumor immune responses
While many patients with melanoma are now benefiting from the introduction of immunotherapies into the clinic, many do not respond and we need to better understand the factors that are crucial in driving a successful immune cell-mediated tumor clearance. In this study, we will use sequencing methods to better understand the necessary components of tumors responding to immunotherapy by using murine models of melanoma.